Global Guillain-Barré Syndrome Market Growth (Status and Outlook) 2022-2028
- LP 4924726
- 85 Pages
- March 2022
- Medical Devices
The United States Guillain-Barré Syndrome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Guillain-Barré Syndrome market, reaching US$ million by the year 2028. As for the Europe Guillain-Barré Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Guillain-Barré Syndrome players cover Grifols, CSL Behring, Octapharma, and Nihon Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Guillain-Barré Syndrome market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Intravenous Immunoglobulin
Plasma Exchange
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Guillain-Barré Syndrome Market Size 2017-2028
2.1.2 Guillain-Barré Syndrome Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Guillain-Barré Syndrome Segment by Type
2.2.1 Intravenous Immunoglobulin
2.2.2 Plasma Exchange
2.2.3 Others
2.3 Guillain-Barré Syndrome Market Size by Type
2.3.1 Guillain-Barré Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
2.4 Guillain-Barré Syndrome Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others
2.5 Guillain-Barré Syndrome Market Size by Application
2.5.1 Guillain-Barré Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
3 Guillain-Barré Syndrome Market Size by Player
3.1 Guillain-Barré Syndrome Market Size Market Share by Players
3.1.1 Global Guillain-Barré Syndrome Revenue by Players (2020-2022)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Players (2020-2022)
3.2 Global Guillain-Barré Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Guillain-Barré Syndrome by Regions
4.1 Guillain-Barré Syndrome Market Size by Regions (2017-2022)
4.2 Americas Guillain-Barré Syndrome Market Size Growth (2017-2022)
4.3 APAC Guillain-Barré Syndrome Market Size Growth (2017-2022)
4.4 Europe Guillain-Barré Syndrome Market Size Growth (2017-2022)
4.5 Middle East & Africa Guillain-Barré Syndrome Market Size Growth (2017-2022)
5 Americas
5.1 Americas Guillain-Barré Syndrome Market Size by Country (2017-2022)
5.2 Americas Guillain-Barré Syndrome Market Size by Type (2017-2022)
5.3 Americas Guillain-Barré Syndrome Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Guillain-Barré Syndrome Market Size by Region (2017-2022)
6.2 APAC Guillain-Barré Syndrome Market Size by Type (2017-2022)
6.3 APAC Guillain-Barré Syndrome Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Guillain-Barré Syndrome by Country (2017-2022)
7.2 Europe Guillain-Barré Syndrome Market Size by Type (2017-2022)
7.3 Europe Guillain-Barré Syndrome Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Guillain-Barré Syndrome by Region (2017-2022)
8.2 Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2017-2022)
8.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Guillain-Barré Syndrome Market Forecast
10.1 Global Guillain-Barré Syndrome Forecast by Regions (2023-2028)
10.1.1 Global Guillain-Barré Syndrome Forecast by Regions (2023-2028)
10.1.2 Americas Guillain-Barré Syndrome Forecast
10.1.3 APAC Guillain-Barré Syndrome Forecast
10.1.4 Europe Guillain-Barré Syndrome Forecast
10.1.5 Middle East & Africa Guillain-Barré Syndrome Forecast
10.2 Americas Guillain-Barré Syndrome Forecast by Country (2023-2028)
10.2.1 United States Guillain-Barré Syndrome Market Forecast
10.2.2 Canada Guillain-Barré Syndrome Market Forecast
10.2.3 Mexico Guillain-Barré Syndrome Market Forecast
10.2.4 Brazil Guillain-Barré Syndrome Market Forecast
10.3 APAC Guillain-Barré Syndrome Forecast by Region (2023-2028)
10.3.1 China Guillain-Barré Syndrome Market Forecast
10.3.2 Japan Guillain-Barré Syndrome Market Forecast
10.3.3 Korea Guillain-Barré Syndrome Market Forecast
10.3.4 Southeast Asia Guillain-Barré Syndrome Market Forecast
10.3.5 India Guillain-Barré Syndrome Market Forecast
10.3.6 Australia Guillain-Barré Syndrome Market Forecast
10.4 Europe Guillain-Barré Syndrome Forecast by Country (2023-2028)
10.4.1 Germany Guillain-Barré Syndrome Market Forecast
10.4.2 France Guillain-Barré Syndrome Market Forecast
10.4.3 UK Guillain-Barré Syndrome Market Forecast
10.4.4 Italy Guillain-Barré Syndrome Market Forecast
10.4.5 Russia Guillain-Barré Syndrome Market Forecast
10.5 Middle East & Africa Guillain-Barré Syndrome Forecast by Region (2023-2028)
10.5.1 Egypt Guillain-Barré Syndrome Market Forecast
10.5.2 South Africa Guillain-Barré Syndrome Market Forecast
10.5.3 Israel Guillain-Barré Syndrome Market Forecast
10.5.4 Turkey Guillain-Barré Syndrome Market Forecast
10.5.5 GCC Countries Guillain-Barré Syndrome Market Forecast
10.6 Global Guillain-Barré Syndrome Forecast by Type (2023-2028)
10.7 Global Guillain-Barré Syndrome Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Guillain-Barré Syndrome Product Offered
11.1.3 Grifols Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Grifols Main Business Overview
11.1.5 Grifols Latest Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Information
11.2.2 CSL Behring Guillain-Barré Syndrome Product Offered
11.2.3 CSL Behring Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CSL Behring Main Business Overview
11.2.5 CSL Behring Latest Developments
11.3 Octapharma
11.3.1 Octapharma Company Information
11.3.2 Octapharma Guillain-Barré Syndrome Product Offered
11.3.3 Octapharma Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Octapharma Main Business Overview
11.3.5 Octapharma Latest Developments
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Information
11.4.2 Nihon Pharmaceutical Guillain-Barré Syndrome Product Offered
11.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Nihon Pharmaceutical Main Business Overview
11.4.5 Nihon Pharmaceutical Latest Developments
11.5 Akari Therapeutics
11.5.1 Akari Therapeutics Company Information
11.5.2 Akari Therapeutics Guillain-Barré Syndrome Product Offered
11.5.3 Akari Therapeutics Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Akari Therapeutics Main Business Overview
11.5.5 Akari Therapeutics Latest Developments
11.6 China Biologic Products Holdings
11.6.1 China Biologic Products Holdings Company Information
11.6.2 China Biologic Products Holdings Guillain-Barré Syndrome Product Offered
11.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 China Biologic Products Holdings Main Business Overview
11.6.5 China Biologic Products Holdings Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Guillain-Barré Syndrome Product Offered
11.7.3 Biotest Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 Kedrion
11.8.1 Kedrion Company Information
11.8.2 Kedrion Guillain-Barré Syndrome Product Offered
11.8.3 Kedrion Guillain-Barré Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Kedrion Main Business Overview
11.8.5 Kedrion Latest Developments
12 Research Findings and Conclusion
Table 1. Guillain-Barré Syndrome Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Intravenous Immunoglobulin
Table 3. Major Players of Plasma Exchange
Table 4. Major Players of Others
Table 5. Guillain-Barré Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Guillain-Barré Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
Table 8. Guillain-Barré Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Guillain-Barré Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
Table 11. Global Guillain-Barré Syndrome Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Guillain-Barré Syndrome Revenue Market Share by Player (2020-2022)
Table 13. Guillain-Barré Syndrome Key Players Head office and Products Offered
Table 14. Guillain-Barré Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Guillain-Barré Syndrome Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Guillain-Barré Syndrome Market Size Market Share by Regions (2017-2022)
Table 19. Americas Guillain-Barré Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Guillain-Barré Syndrome Market Size Market Share by Country (2017-2022)
Table 21. Americas Guillain-Barré Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
Table 23. Americas Guillain-Barré Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
Table 25. APAC Guillain-Barré Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Guillain-Barré Syndrome Market Size Market Share by Region (2017-2022)
Table 27. APAC Guillain-Barré Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
Table 29. APAC Guillain-Barré Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
Table 31. Europe Guillain-Barré Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Guillain-Barré Syndrome Market Size Market Share by Country (2017-2022)
Table 33. Europe Guillain-Barré Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
Table 35. Europe Guillain-Barré Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Guillain-Barré Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Guillain-Barré Syndrome
Table 44. Key Market Challenges & Risks of Guillain-Barré Syndrome
Table 45. Key Industry Trends of Guillain-Barré Syndrome
Table 46. Global Guillain-Barré Syndrome Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Guillain-Barré Syndrome Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Guillain-Barré Syndrome Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Guillain-Barré Syndrome Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Guillain-Barré Syndrome Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Guillain-Barré Syndrome Market Size Market Share Forecast by Application (2023-2028)
Table 52. Grifols Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 53. Grifols Guillain-Barré Syndrome Product Offered
Table 54. Grifols Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Grifols Main Business
Table 56. Grifols Latest Developments
Table 57. CSL Behring Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 58. CSL Behring Guillain-Barré Syndrome Product Offered
Table 59. CSL Behring Main Business
Table 60. CSL Behring Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. CSL Behring Latest Developments
Table 62. Octapharma Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 63. Octapharma Guillain-Barré Syndrome Product Offered
Table 64. Octapharma Main Business
Table 65. Octapharma Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Octapharma Latest Developments
Table 67. Nihon Pharmaceutical Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 68. Nihon Pharmaceutical Guillain-Barré Syndrome Product Offered
Table 69. Nihon Pharmaceutical Main Business
Table 70. Nihon Pharmaceutical Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Nihon Pharmaceutical Latest Developments
Table 72. Akari Therapeutics Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 73. Akari Therapeutics Guillain-Barré Syndrome Product Offered
Table 74. Akari Therapeutics Main Business
Table 75. Akari Therapeutics Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Akari Therapeutics Latest Developments
Table 77. China Biologic Products Holdings Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 78. China Biologic Products Holdings Guillain-Barré Syndrome Product Offered
Table 79. China Biologic Products Holdings Main Business
Table 80. China Biologic Products Holdings Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. China Biologic Products Holdings Latest Developments
Table 82. Biotest Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 83. Biotest Guillain-Barré Syndrome Product Offered
Table 84. Biotest Main Business
Table 85. Biotest Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Biotest Latest Developments
Table 87. Kedrion Details, Company Type, Guillain-Barré Syndrome Area Served and Its Competitors
Table 88. Kedrion Guillain-Barré Syndrome Product Offered
Table 89. Kedrion Main Business
Table 90. Kedrion Guillain-Barré Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Kedrion Latest Developments
List of Figures
Figure 1. Guillain-Barré Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Guillain-Barré Syndrome Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Guillain-Barré Syndrome Market Size Market Share by Type in 2021
Figure 7. Guillain-Barré Syndrome in Hospital Pharmacies
Figure 8. Global Guillain-Barré Syndrome Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Guillain-Barré Syndrome in Retail Pharmacies
Figure 10. Global Guillain-Barré Syndrome Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Guillain-Barré Syndrome in Others
Figure 12. Global Guillain-Barré Syndrome Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Guillain-Barré Syndrome Market Size Market Share by Application in 2021
Figure 14. Global Guillain-Barré Syndrome Revenue Market Share by Player in 2021
Figure 15. Global Guillain-Barré Syndrome Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Guillain-Barré Syndrome Market Size 2017-2022 ($ Millions)
Figure 17. APAC Guillain-Barré Syndrome Market Size 2017-2022 ($ Millions)
Figure 18. Europe Guillain-Barré Syndrome Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Guillain-Barré Syndrome Market Size 2017-2022 ($ Millions)
Figure 20. Americas Guillain-Barré Syndrome Value Market Share by Country in 2021
Figure 21. Americas Guillain-Barré Syndrome Consumption Market Share by Type in 2021
Figure 22. Americas Guillain-Barré Syndrome Market Size Market Share by Application in 2021
Figure 23. United States Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Guillain-Barré Syndrome Market Size Market Share by Region in 2021
Figure 28. APAC Guillain-Barré Syndrome Market Size Market Share by Application in 2021
Figure 29. China Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Guillain-Barré Syndrome Market Size Market Share by Country in 2021
Figure 36. Europe Guillain-Barré Syndrome Market Size Market Share by Type in 2021
Figure 37. Europe Guillain-Barré Syndrome Market Size Market Share by Application in 2021
Figure 38. Germany Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Guillain-Barré Syndrome Market Size Market Share by Application in 2021
Figure 46. Egypt Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Guillain-Barré Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 52. APAC Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 53. Europe Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 55. United States Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 56. Canada Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 59. China Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 60. Japan Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 61. Korea Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 63. India Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 64. Australia Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 65. Germany Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 66. France Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 67. UK Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 68. Italy Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 69. Russia Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 70. Spain Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 73. Israel Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Guillain-Barré Syndrome Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
